Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
The fair value of the options granted
as discussed above and the related assumptions used in the Black-Scholes option model used to value the options granted were as
follows:
|
|
Employee Stock Option Granted |
|
|
|
July 27, 2017 |
|
Weighted-average fair value per share |
|
$ |
1.88 |
|
Risk -free interest rate (1) |
|
|
1.98 |
% |
Expected volatility of stock (2) |
|
|
53.15 |
% |
Dividend yield |
|
|
None |
|
Expected option life (3) |
|
|
6.0 years |
|
|
|
Outside Director Stock Options Granted |
|
|
|
January 18, 2018 |
|
|
July 26, 2018 |
|
|
January 13, 2017 |
|
|
July 27, 2017 |
|
Weighted-average fair value per share |
|
$ |
2.55 |
|
|
|
3.02 |
|
|
$ |
2.63 |
|
|
$ |
2.48 |
|
Risk -free interest rate (1) |
|
|
2.62 |
% |
|
|
2.98 |
% |
|
|
2.40 |
% |
|
|
2.32 |
% |
Expected volatility of stock (2) |
|
|
57.29 |
% |
|
|
55.34 |
% |
|
|
56.32 |
% |
|
|
57.21 |
% |
Dividend yield |
|
|
None |
|
|
|
None |
|
|
|
None |
|
|
|
None |
|
Expected option life (3) |
|
|
10.0 years |
|
|
|
10.0 years |
|
|
|
10.0 years |
|
|
|
10.0 years |
|
(1) |
The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option. |
(2) |
The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option. |
(3) |
The expected option life is based on historical exercises and post-vesting data. |
|
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs |
The following table summarizes stock-based
compensation recognized for the three and nine months ended September 30, 2018 and 2017 for our employee and director stock options.
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
Stock Options |
|
September 30, |
|
|
September 30, |
|
|
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
Employee Stock Options |
|
$ |
37,000 |
|
|
$ |
22,000 |
|
|
$ |
110,000 |
|
|
$ |
43,000 |
|
Director Stock Options |
|
|
15,000 |
|
|
|
12,000 |
|
|
|
33,000 |
|
|
|
32,000 |
|
Total |
|
$ |
52,000 |
|
|
$ |
34,000 |
|
|
$ |
143,000 |
|
|
$ |
75,000 |
|
|
Schedule of Stock Options Roll Forward |
The summary of the Company’s total
Stock Option Plans as of September 30, 2018 and September 30, 2017, and changes during the periods then ended, are presented below.
The Company’s Plans consist of the 2017 Stock Plan and the 2003 Plan:
|
|
Shares |
|
|
Weighted Average Exercise
Price
|
|
|
Weighted Average Remaining Contractual Term
(years)
|
|
|
Aggregate Intrinsic Value (2) |
|
Options outstanding January 1, 2018 |
|
|
624,800 |
|
|
$ |
4.42 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
18,000 |
|
|
|
4.22 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(10,000 |
) |
|
|
3.65 |
|
|
|
|
|
|
|
|
|
Forfeited/expired |
|
|
(16,800 |
) |
|
|
11.70 |
|
|
|
|
|
|
|
|
|
Options outstanding end of period (1) |
|
|
616,000 |
|
|
$ |
4.23 |
|
|
|
5.0 |
|
|
$ |
279,630 |
|
Options exercisable at September 30, 2018(1) |
|
|
227,333 |
|
|
$ |
5.17 |
|
|
|
4.6 |
|
|
$ |
72,296 |
|
Options exercisable and expected to be vested at September 30, 2018 |
|
|
616,000 |
|
|
$ |
4.23 |
|
|
|
5.0 |
|
|
$ |
279,630 |
|
|
|
Shares |
|
|
Weighted Average Exercise
Price
|
|
|
Weighted Average Remaining Contractual Term
(years)
|
|
|
Aggregate Intrinsic Value (2) |
|
Options outstanding January 1, 2017 |
|
|
247,200 |
|
|
$ |
6.69 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
318,000 |
|
|
|
3.65 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
─ |
|
|
|
─ |
|
|
|
|
|
|
|
|
|
Forfeited/expired |
|
|
(50,400 |
) |
|
|
8.95 |
|
|
|
|
|
|
|
|
|
Options outstanding end of period (1) |
|
|
514,800 |
|
|
$ |
4.59 |
|
|
|
5.7 |
|
|
$ |
65,490 |
|
Options exercisable at September 30, 2017(1) |
|
|
169,467 |
|
|
$ |
6.45 |
|
|
|
4.8 |
|
|
$ |
17,490 |
|
Options exercisable and expected to be vested at September 30, 2017 |
|
|
514,800 |
|
|
$ |
4.59 |
|
|
|
5.7 |
|
|
$ |
65,490 |
|
(1) |
Options with exercise prices ranging from $2.79 to $13.35 |
(2) |
The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price |
|